Skip to navigation Skip to main content
  • Home
  • About us
  • Vision & Mission
  • Research Focus
    • spinal cord injury
    • neuroregeneration
    • novel molecules
    • peptide therapies
  • Projects
  • Insights
    • Articles
  • News & Updates
  • Contact us
Search
Menu

spinal cord injury

23 Feb

NVG-291: Exploring Its Potential in Spinal Cord Injury and Neuroprotection

Introduction NVG-291 is a promising experimental agent designed to address neuroinflammation, a key...
Continue reading
23 Feb

Therapeutic Directions

The biological complexity of spinal cord injury (SCI) makes it unlikely that a single intervention c...
Continue reading
23 Feb

Barriers to Repair – Spinal Cord Injury

Introduction Repair in the central nervous system is profoundly limited. After spinal cord injury...
Continue reading
23 Feb

Biology of Injury – Spinal Cord Injury

Introduction Spinal cord injury (SCI) sets off a complex series of biological events that extend ...
Continue reading
22 Feb

BPC-157 – An Emerging Candidate in Spinal Cord Injury Research

BPC-157 (Body Protection Compound-157) is a synthetic peptide composed of 15 amino acids, originally...
Continue reading
  • 1
  • 2
  • No.6&7, 10th floor, Mellat Tower, Vali-e-Asr St, Tehran, Iran
  • +98 21 2623 0998
  • +98 912 388 3863
  • info@neuraldaroo.com
  • behrad.khalaf@gmail.com

Quick Links:

  • Research Focus
  • About Us
  • News & Updates
  • Contact Us

Location

© Neural Drug Research
  • Home
  • About us
  • Vision & Mission
  • Research Focus
    • spinal cord injury
    • neuroregeneration
    • novel molecules
    • peptide therapies
  • Projects
  • Insights
    • Articles
  • News & Updates
  • Contact us
  • Languages
    • You need WPML plugin for this to work. You can remove it from Header builder.